Floatz logo

N-Methylnaltrexone Bromide

Constipation

Bausch Health Americas, Inc.Phase 3Dormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Constipation cohort.

Asset / SponsorPhaseRating
Lubiprostone
University of Rochester
Phase 4BB
Moa-728
Bausch Health Americas, Inc.
Phase 2BB
Oxycodone
Mundipharma Research GmbH & Co KG
Phase 3BB
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
Mundipharma Research GmbH & Co KG
Phase 3BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
University of Illinois College of Medicine at Peoria
Phase 4BB

View all 28 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →